Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 2 of 3: Mean cell count and mean normalized growth rate inhibition values across all replicates. - Dataset (ID:20257)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Taxol | 0.00016596 | uM | 3 | 312.50 | 257.33 | 534.33 | 445.42 | 1.1986 | 1.5255 |
| SK-BR-3 | Taxol | 0.00033113 | uM | 3 | 312.50 | 257.33 | 428.33 | 445.42 | 0.9630 | 0.9155 |
| SK-BR-3 | Taxol | 0.001 | uM | 3 | 312.50 | 257.33 | 399.33 | 445.42 | 0.8968 | 0.7437 |
| SK-BR-3 | Taxol | 0.0031623 | uM | 3 | 312.50 | 257.33 | 313.00 | 445.42 | 0.7024 | 0.2808 |
| SK-BR-3 | Taxol | 0.01 | uM | 3 | 312.50 | 257.33 | 236.67 | 445.42 | 0.5302 | -0.1013 |
| SK-BR-3 | Taxol | 0.031623 | uM | 3 | 312.50 | 257.33 | 250.33 | 445.42 | 0.5621 | -0.0348 |
| SK-BR-3 | Taxol | 0.1 | uM | 3 | 312.50 | 257.33 | 222.00 | 445.42 | 0.4987 | -0.1658 |
| SK-BR-3 | Taxol | 0.31623 | uM | 3 | 312.50 | 257.33 | 254.67 | 445.42 | 0.5711 | -0.0158 |
| SK-BR-3 | Taxol | 1 | uM | 3 | 312.50 | 257.33 | 239.67 | 445.42 | 0.5373 | -0.0885 |
| SK-BR-3 | Etoposide | 0.0033113 | uM | 3 | 312.50 | 257.33 | 517.00 | 446.25 | 1.1618 | 1.4428 |
| SK-BR-3 | Etoposide | 0.01 | uM | 3 | 312.50 | 257.33 | 418.67 | 446.25 | 0.9359 | 0.8289 |
| SK-BR-3 | Etoposide | 0.031623 | uM | 3 | 312.50 | 257.33 | 428.67 | 446.25 | 0.9609 | 0.9019 |
| SK-BR-3 | Etoposide | 0.1 | uM | 3 | 312.50 | 257.33 | 518.00 | 446.25 | 1.1644 | 1.4569 |
| SK-BR-3 | Etoposide | 0.31623 | uM | 3 | 312.50 | 257.33 | 297.33 | 446.25 | 0.6721 | 0.2265 |
| SK-BR-3 | Etoposide | 1 | uM | 3 | 312.50 | 257.33 | 308.33 | 446.25 | 0.6939 | 0.2651 |
| SK-BR-3 | Etoposide | 3.1623 | uM | 3 | 312.50 | 257.33 | 250.33 | 446.25 | 0.5653 | -0.0171 |
| SK-BR-3 | Etoposide | 10 | uM | 3 | 312.50 | 257.33 | 249.00 | 446.25 | 0.5582 | -0.0451 |
| SK-BR-3 | Etoposide | 19.9526 | uM | 3 | 312.50 | 257.33 | 235.00 | 446.25 | 0.5269 | -0.1117 |
| SK-BR-3 | Nilotinib | 0.0033113 | uM | 3 | 312.50 | 257.33 | 535.00 | 446.25 | 1.1999 | 1.5300 |
| SK-BR-3 | Nilotinib | 0.01 | uM | 3 | 312.50 | 257.33 | 539.67 | 446.25 | 1.2054 | 1.5182 |
| SK-BR-3 | Nilotinib | 0.031623 | uM | 3 | 312.50 | 257.33 | 466.00 | 446.25 | 1.0500 | 1.1664 |
| SK-BR-3 | Nilotinib | 0.1 | uM | 3 | 312.50 | 257.33 | 510.67 | 446.25 | 1.1461 | 1.3917 |
| SK-BR-3 | Nilotinib | 0.31623 | uM | 3 | 312.50 | 257.33 | 544.67 | 446.25 | 1.2233 | 1.6093 |
| SK-BR-3 | Nilotinib | 1 | uM | 3 | 312.50 | 257.33 | 512.33 | 446.25 | 1.1501 | 1.4043 |
| SK-BR-3 | Nilotinib | 3.1623 | uM | 3 | 312.50 | 257.33 | 440.00 | 446.25 | 0.9852 | 0.9621 |